BAYER AG
π©πͺGermany
- Country
- π©πͺGermany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
A Study to Learn About How BAY2927088 Affects the Level of Midazolam in the Blood When Both Drugs Are Taken Together in Healthy Participants
Phase 1
Completed
- Conditions
- Advanced Non-small Cell Lung CancerEGFR MutationHealthy VolunteersHER2 Mutation
- Interventions
- First Posted Date
- 2024-04-11
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Bayer
- Target Recruit Count
- 15
- Registration Number
- NCT06360211
- Locations
- πΊπΈ
Parexel Baltimore - Early Phase Clinical Unit, Baltimore, Maryland, United States
A Study to Learn About How Itraconazole and Carbamazepine Affect the Level of BAY2927088 in the Blood When These Drugs Are Taken Together by Healthy Participants
Phase 1
Completed
- Conditions
- Advanced Non-small Cell Lung CancerEGFR MutationHER2 MutationHealthy Volunteers
- Interventions
- First Posted Date
- 2024-04-05
- Last Posted Date
- 2024-06-20
- Lead Sponsor
- Bayer
- Target Recruit Count
- 30
- Registration Number
- NCT06348888
- Locations
- πΊπΈ
Parexel Baltimore - Early Phase Clinical Unit, Baltimore, Maryland, United States
A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer or Other Select Solid Cancers
Phase 1
Completed
- Conditions
- Solid TumorsHepatocellular Carcinoma (HCC)
- Interventions
- First Posted Date
- 2024-04-03
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- Bayer
- Target Recruit Count
- 14
- Registration Number
- NCT06345001
- Locations
- πΊπΈ
HonorHealth Research Institute, Scottsdale, Arizona, United States
πΊπΈCity of Hope - Duarte Cancer Center, Duarte, California, United States
πΊπΈUniversity of Southern California (USC) - Norris Comprehensive Cancer Center, Los Angeles, California, United States
An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea
Recruiting
- Conditions
- Non-metastatic Castration-resistant Prostate CancerMetastatic Hormone-sensitive Prostate Cancer
- Interventions
- First Posted Date
- 2024-03-27
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Bayer
- Target Recruit Count
- 600
- Registration Number
- NCT06334120
- Locations
- π°π·
Multiple locations, Multiple Locations, Korea, Republic of
A Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy Participants
Phase 1
Completed
- Conditions
- EGFR MutationHER2 MutationAdvanced Non-small Cell Lung CancerHealthy Volunteers
- Interventions
- First Posted Date
- 2024-03-26
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- Bayer
- Target Recruit Count
- 15
- Registration Number
- NCT06329895
- Locations
- π¬π§
PAREXEL International Early Phase Clinical Unit (London), Harrow, United Kingdom
An Observational Study to Learn More About Treatment With Regorafenib in People With Advanced Gastrointestinal Stromal Tumors in the United States
Completed
- Conditions
- Advanced Gastrointestinal Stromal Tumor
- Interventions
- First Posted Date
- 2024-03-20
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Bayer
- Target Recruit Count
- 136
- Registration Number
- NCT06321055
- Locations
- πΊπΈ
Bayer, Whippany, New Jersey, United States
An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom (UK)
- First Posted Date
- 2024-03-18
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 200
- Registration Number
- NCT06315556
- Locations
- π¬π§
Many locations, Multiple Locations, United Kingdom
A First-in-Human Study to Learn How Well a Bi-Layer Calcium Carbonate Antacid Tablet Works Compared to a Standard, Non-Layered Calcium Carbonate Tablet in Healthy Male Participants
Phase 1
Completed
- Conditions
- Nocturnal Stomach Acid Related SymptomsHeartburnIndigestionStomach Acid Related SymptomsHealthy Volunteers
- Interventions
- Drug: bi-layer calcium carbonate tablet (BAY1180654)Drug: Immediate release calcium carbonate tablet (BAY1180654)
- First Posted Date
- 2024-03-05
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Bayer
- Target Recruit Count
- 21
- Registration Number
- NCT06293326
- Locations
- π¬π§
BDD Pharma Bio-imaging Unit, Glasgow, United Kingdom
An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
Recruiting
- Conditions
- Chronic Kidney DiseaseType 2 Diabetes Mellitus
- Interventions
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- Bayer
- Target Recruit Count
- 50000
- Registration Number
- NCT06278207
- Locations
- π―π΅
Many Locations, Multiple Locations, Japan
π©πͺBayer, Berlin, Germany
An Observational Study to Learn More About How Safe Treatment With Rivaroxaban is in Children in Japan With Venous Thromboembolism
Completed
- Conditions
- Venous Thromboembolism
- Interventions
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Bayer
- Target Recruit Count
- 320
- Registration Number
- NCT06278051
- Locations
- π―π΅
Many facilities, Multiple Locations, Japan
π―π΅Bayer, Osaka, Japan
Β© Copyright 2025. All Rights Reserved by MedPath